1982•Cancer Chemotherapy and PharmacologyRequires access

Levonantradol, a new antiemetic with a high rate of side-effects for the prevention of nausea and vomiting in patients receiving cancer chemotherapy

R Joss, Renato L. Galeazzi, Annakatharina Bischoff, Do D, Aron Goldhirsch, Kurt Brunner

Open publisher page 8 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Nausea, Antiemetic, Vomiting, Medicine, Chemotherapy, Cancer chemotherapy, Side effect (computer science), Cancer

Back to paper search Browse research topics Original source

Levonantradol, a new antiemetic with a high rate of side-effects for the prevention of nausea and vomiting in patients receiving cancer chemotherapy — Research Paper | ScholarLens